Skip to content

What Is a Biologics License Application (BLA) in the UAE and Who Needs One?


What Is a Biologics License Application (BLA) in the UAE - Hawkridge Corp

The UAE is fast becoming a center of pharmaceutical and biotechnology research in the Middle East region. Due to the development in the health care industry, many organizations would like to create innovative biological products such as vaccines, gene therapies, and monoclonal antibodies. To legally and safely introduce these new products, you must file a BLA. If you are unfamiliar with biologics registration UAE requirements, this guide breaks down everything you need to know what a biologics license application is, what products it covers, who needs one, and how the approval process works in the UAE.

What Is a Biologics License Application (BLA)?

A Biologics License Application refers to a legal and official application filed to the concerned authority for marketing a biologic. While chemical drugs are manufactured through chemical synthesis, biologics are products manufactured by using live organisms. As such, biologics are much more complicated compared to other drugs, which is why there is also a need to have a complicated biologics license application process for approval.

In the UAE, the biologics license application process is mainly facilitated by the Ministry of Health and Prevention (MOHAP) in association with the Emirates Drug Establishment (EDE). EDE is an organization that has been created to oversee the regulation of pharmaceuticals and medical goods at the federal level in the UAE.

Which Types of Products Need a BLA?

Any biological product that must go through a licensing process would need to file a biologics license application in order to be marketed commercially within the UAE. Biological products registration UAE includes all kinds of products, like:

  • Vaccines and immunological products
  • Monoclonal antibodies for oncology and autoimmune diseases
  • Therapies based on gene and cell therap
  • Blood and blood derivatives
  • Recombinant proteins, for instance insulin and erythropoietin
  • Biosimilar products which closely resemble an existing reference biologic

If your product falls into any of these categories, you will need a biologics license application to legally market it in the UAE. Trying to sell a biologic product without one can result in serious legal and regulatory penalties.

Types of Biologics License Applications in the UAE

There are different types of biologics license applications depending on whether your product is new, a biosimilar, or a variation of an existing approval.

New Biologics License Application

This is submitted when a biologic is seeking its first authorisation for sale in the UAE. It is the most comprehensive type of biologics license application, requiring a full dossier of clinical, preclinical, and manufacturing data. Companies bringing novel therapy to the UAE market for the first time will always start here.

Abbreviated Biologics License Application (for Biosimilars)

This applies to biosimilars products that are highly similar to an already approved reference biologic. While the documentation requirements are somewhat reduced, a rigorous comparability study must still demonstrate that the biosimilar meets the same standards of safety, quality, and efficacy as the original. Biologics registration UAE for biosimilars is closely aligned with international guidelines, including those from the WHO and the EMA.

When Do You Need a Biologics License Application in the UAE?

If any of the following applies to your organization, a biologics license application is compulsory in the UAE:

  • International pharmaceutical companies entering the UAE or GCC market with a biologic product
  • Local distributors acting as Marketing Authorisation Holders (MAH) for a foreign manufacturer
  • Biotech companies launching gene or cell therapies in the region
  • Vaccine manufacturers seeking commercial distribution rights in the UAE
  • Companies seeking approval for biosimilar versions of existing treatments

It should be taken into consideration that the manufacturer should authorize the presence of a licensed entity of the UAE to function as the authorized representative of the product. Usually, such an authorized representative is a licensed medical warehouse that conducts all regulatory activities with regard to MOHAP and EDE.

What Are the Required Documents in a Biologics License Application?

A biologics license application in the United Arab Emirates needs an elaborate documentation process to be successful. However, some documents are always essential no matter what products you are registering for and these documents include:

  1. Product information: List the active ingredients, product formulation, and manufacturing processes
  2. CTD/eCTD application form: The Common Technical Document (CTD) format is required by MOHAP
  3. Clinical and preclinical studies: Safety and efficacy of the product
  4. Certificate of good manufacturing practice (GMP): Certificate from the manufacturing facility confirming GMP compliance
  5. Certificate of free sale (CFS): Certificate proving that the product is authorized in the country of manufacture
  6. Labels and packaging details: Include both Arabic and English versions of the label along with storage instructions
  7. Power of Attorney (POA): This must be notarized and empower your UAE representative to conduct business on your behalf
  8. Registration documents of the company: Trade license and other legal entity documentation

Benefits of Receiving an Approval of Your BLA in the UAE

In addition to meeting the regulations, obtaining a biologics license application is crucial from a commercial standpoint as well.

  • Access to the GCC market: UAE approval is considered a precedent for biologics registration in other GCC countries, such as Saudi Arabia, Kuwait, and Bahrain
  • Faster market entry: The MOHAP provides expedited approvals for innovative drugs that address an important unmet need
  • Global approval: Approval of biological products in the UAE meets global standards, making it easier to get approvals elsewhere
  • Research support: The UAE health authority promotes clinical trial programs in conjunction with the biologics license application

Common Challenges When Applying for a BLA in the UAE

The application process for a BLA is complicated. Some common problems encountered by companies new to UAE regulation include the following:

  • Incomplete dossier lack of stability data, bioequivalence data, or certificates of GMP manufacture
  • Labeling problems such as non-compliance of Arabic translation or missing mandatory labeling content
  • Incorrect product classification leading to submission under the wrong regulatory pathway
  • Pharmacovigilance (PV) officer issues MOHAP requires a locally resident and qualified PV officer as part of the biologics license application approval conditions

These mistakes could lead to serious delays or even complete denial of your biologics registration UAE application. It is wise to consult a regulatory affairs specialist at the very beginning to avoid wasting valuable time and money.

What Hawkridge Corp can offer to assist you in navigating the BLA route

Here at Hawkridge Corp, we excel at guiding pharmaceutical and biotechnology companies through the process of registering their biologics in the UAE in a smooth and straightforward way. We have a professional regulatory team well-versed in making submissions compliant with the MOHAP and EDE rules.

We offer a comprehensive service covering dossier submission according to the CTD/eCTD standards, liaison with authorised local representatives and even assistance with pharmacovigilance following approval. Furthermore, if you are an international firm that is new to the UAE, we will serve as your local representative in all matters relating to regulation.

Whether you are marketing a novel biologic or seeking registration approval for a biosimilar in the UAE, or other parts of the GCC region, we have the experience to help you succeed in your project.

Conclusion

Getting an approval in biologics license application in the UAE is an important step in ensuring that a company succeeds in offering advanced biological products in the Gulf countries. This entails lots of documentation, rigorous regulation, and having a local partner who understands biological products registration UAE requirements. Having knowledge of biological products registration UAE early in the planning phase ensures that you achieve your goals and minimize risks. Should you be ready to get an approval in biologics license application or have questions about biological products registration UAE, get in touch with Hawkridge Corp today.